Navigation Links
Benda Pharmaceutical Announces Resignation of Board Member
Date:6/19/2008

HUBEI PROVINCE, China, June 19 /Xinhua-PRNewswire-FirstCall/ -- Benda Pharmaceutical, Inc. (OTC Bulletin Board: BPMA), a China-based pharmaceutical company producing both Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, today announced that Charles Mo has resigned from the Board of Directors of Benda Pharmaceutical, Inc., effective June 15, 2008. Mr. Mo joined the Board in 2007 and served as an independent director as well as Chairman of the Audit Committee.

"On behalf of the board of directors and management team, I would like to thank Mr. Mo for his many contributions and dedicated service to the Company. His leadership and vision have been invaluable to the Company and we wish him well in his future endeavors," said Charles Wan, Chief Executive Officer of Benda Pharmaceutical. "Meanwhile, the Board is conducting a thorough replacement search."

About Benda Pharmaceutical, Inc.

Benda Pharmaceutical, Inc. ( http://www.bendapharma.com ), a China-based pharmaceutical company, produces traditional Chinese and conventional medicines, as well as Gendicine(R), a commercialized gene therapy medicine for the treatment of cancer.

Safe Harbor Statement

The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward- looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor for forward-looking statements contained in the Securities Litigation Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act.


'/>"/>
SOURCE Benda Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Benda Pharmaceutical Reports First Quarter 2008 Financial Results
2. Benda Pharmaceutical Appoints Jun Tang to Board of Directors
3. Benda Pharmaceutical Reports Fourth Quarter and Full Year 2007 Financial Results
4. HighPoint Solutions Signs Deal to Implement Model N Managed Care and Government Pricing System for Specialty Pharmaceutical Company
5. Transcept Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference
6. Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC
7. Strativa Pharmaceuticals Acquires Commercialization Rights to Thin Film Formulation of Ondansetron From MonoSol Rx
8. MonoSol Rx Licenses Thin Film Formulation of Ondansetron to Strativa Pharmaceuticals, a Division of Par Pharmaceutical
9. Verus Pharmaceuticals Announces Divestiture of Pediatric GI Development Program to Meritage Pharma
10. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
11. Worldwide Pharmaceutical Industry, Aid Organizations Warn of Second Disaster in Myanmar
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... Grimsby, Ontario (PRWEB) , ... March 23, 2017 , ... The MBI “Hall of Fame” ... or whose acts have had a significant impact on the careers of all others involved. ... with NRB Inc. was inducted into the MBI’s Hall of Fame. The induction took ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... serving the families and businesses of the Norwalk and Vermillion areas, celebrates ... Recovery Center (N.O.R.A.) is a nonprofit, community-based substance abuse prevention and peer ...
(Date:3/23/2017)... ... 2017 , ... Benefits delivery trailblazer, Hodges-Mace, LLC, ... benefits dashboard solving one of the top frustrations in employee benefits – how ... time, employees can access up-to-date information and account balances for all of their ...
(Date:3/23/2017)... Angeles, CA (PRWEB) , ... March 23, 2017 ... ... A funding investment in Los Angeles based healthcare technology company California Healthcom Group ... portfolio into the US, and healthcare arena. With headquarters in California, CHG is ...
(Date:3/23/2017)... ... 23, 2017 , ... The TouchPoint Solution, home of Buzzies *, is ... anxiety. , “Buzzies change the way we interact with stress and live our ... its launch date in December 2016, The TouchPoint Solution has sold more than $750,000 ...
Breaking Medicine News(10 mins):
(Date:3/23/2017)... Research and Markets has announced the addition of the ... 2025" report to their offering. ... The Global Cryostat Market is poised to ... to reach approximately $3.5 billion by 2025. This industry ... segments on global as well as regional levels presented in the ...
(Date:3/23/2017)... -- Executive Summary ... research (inputs from industry experts, companies, stakeholders) and ... analysis of global heart valve devices market on ... Procedure By Technique (Mechanical, Bioprosthetic, Transcatheter Aortic Valve ... Valvuloplasty, Transcatheter Mitral Valve Repair (TMVR)), By Region ...
(Date:3/23/2017)... Iowa , March 23, 2017   BioSpace ... career resource, has partnered with Indiana Biosciences Research ... organizations and educational institutions to bring the ... the first-ever BioIndiana Hotbed map, an artistic representation of ... print was presented to Vice President Mike Pence ...
Breaking Medicine Technology: